Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448935) titled 'One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS' on Feb. 26.
Study Type: Observational
Primary Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Condition:
AL Amyloidosis
POEMS Syndrome
Multiple Myeloma
Recruitment Status: Recruiting
Date of First Enrollment: November 28, 2025
Target Sample Size: 100
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/NCT07448935
Published by HT Digital Content Services with permission from Health Daily Digest....